Back to search

Article

Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancer

2024-07-01

Abstract excerpt

<title>Abstract</title> <p>Background Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment for locally advanced rectal cancer, but only 20–40% of patients completely respond to this treatment. Methods To define the molecular features that are associated with response to nCRT, we generated and collected genomic and transcriptomic data from 712 cancers prior to treatment from our own data and from publi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f477134b-5f6a-51e9-980a-a638c2de2dcf
DOI
10.21203/rs.3.rs-4456000/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerDOI 10.21203/rs.3.rs-4456000/v1
Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.Semantic proximity
Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.Semantic proximity
Genetic Determinants of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Identified by Whole Exome Sequencing.Semantic proximity
The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.Semantic proximity
KRASG12V/A146T mutations are associated with nCRT resistance via enhanced DNA double-strand break repair and support a deep learning prediction framework in LARC.Semantic proximity
A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer.Semantic proximity
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal CancerSemantic proximity
Tumor microenvironment remodeling after neoadjuvant chemoradiotherapy in local advanced rectal cancer revealed by single-cell RNA sequencingSemantic proximity
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.Semantic proximity
Response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT pathway dysregulation and high tumour mutational burdenSemantic proximity
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapySemantic proximity
Gene expression profile is associated with chemoradiation resistance in rectal cancerSemantic proximity
Select a neighboring publication to make it the new centre.